Skip to main content
dose.wiki is still in beta. Entries may contain inaccuracies and/or lack citations. See our docs for more info.

2C-T-2

2C-T-2 molecule structure2C-T-2 molecule structure
2,5-Dimethoxy-4-ethylthiophenethylamine
Rosy

2C-T-2 is a synthetic psychedelic of the substituted phenethylamine class and a member of the 2C-x family1, derived from systematic modification of the mescaline molecule. First synthesized by Alexander Shulgin in 1981 and later described in his book PiHKALcitation needed, it is one of his "magical half-dozen" — his self-rated most important phenethylamine compounds. 2C-T-2 is notably dose-sensitive and recognized for its strong visual effects and intense body load.

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~3 mg
Light3-10 mg
Moderate10-20 mg
Strong20-25 mg
Heavy25+ mg

Onset can be slow, with some reports describing an hour or more before effects fully develop.

Duration

Onset30-60 minutes
Peak2.5-5 hours
Offset1-2 hours
After Effects2-4 hours
Total5-10 hours

Subjective Effects

Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.

Effects vary widely by individual, dose, and context.

Physical

Tactile enhancementStomach crampsVasoconstrictionTemperature regulation loss

Cognitive

The head space of 2C-T-2 is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high dosages.

Visual

Geometry

The visual geometry of 2C-T-2 can be described as somewhat similar in appearance to that of ayahuasca, psilocin, and 4-AcO-DMT, with mystical and shamanic undertones which combine with synthetic digital undertones reminiscent of LSD or 2C-E. 2C-T-2's geometry can be comprehensively described as intricate in complexity, abstract in form, organic but somewhat synthetic in style, structured in organization, brightly lit and multicoloured in scheme, glossy in shading, rounded in edges, large in size, fast in speed, smooth in motion, mostly angular in corners, immersive in depth and consistent in intensity. The visuals have a contradictory 'natural' and 'synthetic' feel to them which is reminiscent of DOC or 2C-P. Higher dosages are more likely to result in states of Level 8B visual geometry, but may also lead into Level 8A visual geometry.

Hallucinatory States

2C-T-2 produces a full range of high level hallucinatory states in a fashion that is more consistent and reproducible than that of many other commonly used psychedelics, particularly in comparison to other substances within the phenethylamine family.

Transformations

Auditory

The auditory effects of 2C-T-2 are more common in their occurrence than many more commonly used psychedelics.

Forked from Subjective Effect Documentation byJosie Kins November 2014.

See also: Psychedelic Intensity Scale, Effects of psychedelics (visual, cognitive, miscellaneous)

Reagent Testing

Expected colorimetric results for common reagent tests. Colors show reaction change over 1–2 minutes.

Marquis(MQ)
white → orange1
Mecke(ME)
white → orange2 → red2 → purple2
Mandelin(MD)
yellow2 → purple2
Liebermann(LB)
white → orange2 → purple2 → red2
Powered by PROtestkit.eu

Pharmacology

Pharmacodynamics

2C-T-2 acts primarily as an agonist at serotonin 5-HT2 receptors, including the 5-HT2A, 5-HT2B, and 5-HT2C subtypes.citation needed Partial agonist activity has been reported at the 5-HT2A receptor, and this activity is considered the most likely basis for its psychedelic effects. 2C-T-2 has also been shown to act as a partial agonist at adrenergic receptors. Based on structural analogy with other alkylthio-substituted phenethylamines that act as selective MAO-A inhibitors, 2C-T-2 has been speculated to possess monoamine oxidase inhibitory activity, though this has not been experimentally confirmed.

Pharmacokinetics

A rat-urine GC/MS study tentatively assigned 14 2C-T-2 metabolites. Reported pathways included sulfoxidation, N-acetylation, O-demethylation, S-dealkylation followed by S-methylation, S-ethyl-side-chain hydroxylation, and deamination followed by reduction or oxidation; some products were partly glucuronidated or sulfated. These animal findings do not establish human metabolic proportions, elimination half-life, or route bioavailability.4

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

Unsafe

Avoid

There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.

AmphetaminesCocaineDXMTramadol

Caution

Use caution

These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.

2C-x compounds5-MeO-xxT tryptaminesCannabisDOx compoundsMAOIsMDMAMescalineMXENBOMe compounds
Powered by TripSit

Tolerance

Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.

Full Tolerance
2C-T-2 can produce tolerance almost immediately after use. With consecutive daily use, roughly twice the dose may be needed each time to produce comparable effects.
Baseline Reset
Full baseline tolerance is typically restored after 5-7 days of abstinence, with some sources indicating complete return to baseline within 7 days.
Half Tolerance
Approximately 3 days after use, tolerance is estimated to reduce to half of its peak level.
Cross Tolerance

Serotonergic psychedelics, Other 5-HT2A agonists

Harm Potential

Addiction & Dependence

Psychological

Extremely Low

2C-T-2 is not habit-forming and the desire to use it can actually decrease with use. It is most often self-regulating, though some individuals may use it more frequently than intended.

Physical

Extremely Low

2C-T-2 is not physically addicting. Withdrawal effects following discontinuation have not been reported.

Toxicity

Central Nervous System

In vitro studies have demonstrated potential neurotoxicity to serotonergic and dopaminergic neurons, though the concentrations used (>50 μM) are unlikely to translate to recreational use of the compound.

Psychosis Risk

As with other serotonergic psychedelics, 2C-T-2 may trigger latent psychological and mental conditions in predisposed individuals. Those with a family history of schizophrenia or early onset mental illness should exercise extreme caution. Severe intoxication has been associated with intense hallucinations, agitation, aggression, violence, and dysphoria.citation needed

Seizure Risk

Seizures have been reported as part of severe intoxication with 2C series drugs.5 Individuals with a seizure or convulsive disorder may be at higher risk when taking 2C-T-2.

History & Culture

Discovery and Synthesis

2C-T-2 was first synthesized by Alexander Shulgin in 1981.citation needed That same year, Shulgin discovered its psychedelic properties through self-experimentation, establishing the compound's activity in humans.

Legality

International

2C-T-2 is not listed under the 1961 Single Convention on Narcotic Drugs. It is listed in Schedule II of the 1971 Convention on Psychotropic Substances. It is not listed under the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.

By Country

Illegal32
United States flagUnited StatesIllegal
Argentina flagArgentinaIllegal
Australia flagAustraliaIllegal
Austria flagAustriaIllegal
Belgium flagBelgiumIllegal
Brazil flagBrazilIllegal
Canada flagCanadaIllegal
Chile flagChileIllegal
China flagChinaIllegal
Czech Republic flagCzech RepublicIllegal
Denmark flagDenmarkIllegal
Estonia flagEstoniaIllegal
Finland flagFinlandIllegal
France flagFranceIllegal (analog/blanket ban)
Germany flagGermanyIllegal
Ireland flagIrelandIllegal (analog/blanket ban)
Italy flagItalyIllegal
Japan flagJapanIllegal
Latvia flagLatviaIllegal (analog/blanket ban)
Netherlands flagNetherlandsIllegal
Norway flagNorwayIllegal
Poland flagPolandIllegal
Portugal flagPortugalIllegal
Slovakia flagSlovakiaIllegal
South Africa flagSouth AfricaIllegal (analog/blanket ban)
South Korea flagSouth KoreaIllegal
Spain flagSpainIllegal
Sweden flagSwedenIllegal
Switzerland flagSwitzerlandIllegal
Turkey flagTurkeyIllegal (analog/blanket ban)
Ukraine flagUkraineIllegal
United Kingdom flagUnited KingdomIllegal
Controlled / restricted1
Singapore flagSingaporeRestricted

References

Source Pages

  1. Bluelight: Big & Dandy 2C-T-2 Thread
  2. Disregard Everything I Say
  3. Erowid
  4. Erowid: 2C-T-2 Basics
  5. Isomer Design (TiHKAL/PiHKAL)
  6. PsychonautWiki
  7. TripSit Factsheets
  8. Wikipedia

Citations

  1. Lea Wagmann, Simon D. Brandt, Alexander Stratford, Hans H. Maurer, & Markus R. Meyer. (February 2019). Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases. Drug Testing and Analysis, 11(2), 318–324. https://doi.org/10.1002/dta.24941
  2. Dino Luethi, Daniel Trachsel, Marius C. Hoener, & Matthias E. Liechti. (May 2018). Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs). Neuropharmacology, 134(Pt A), 141–148. https://doi.org/10.1016/j.neuropharm.2017.07.0121
  3. Amy J. Eshleman, Michael J. Forster, Katherine M. Wolfrum, Robert A. Johnson, Aaron Janowsky, & Michael B. Gatch. (March 2014). Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function. Psychopharmacology, 231(5), 875–888. https://doi.org/10.1007/s00213-013-3303-61
  4. New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. Journal of Mass Spectrometry, 40(9), 1157–1172 (September 2005). https://doi.org/10.1002/jms.89012
  5. 2C-T-2 is drug metabolism|metabolized by the monoamine oxidase. (n.d.). https://doi.org/10.1007/s13181-013-0295-x1
  6. Central nervous system (CNS) activity of two new psychoactive compounds. Journal of Psychoactive Drugs, 23(1), 95–96 (January 1991). https://doi.org/10.1080/02791072.1991.104725831
  7. Preliminary results with new psychoactive agents 2C-T-2 and 2C-T-7. (1993). http://www.maps.org/images/pdf/1993_stolaroff_1.pdf12
  8. Decree 593/2019, List of Controlled Substances. argentina.gob.ar (n.d.). https://www.argentina.gob.ar/sites/default/files/listado_de_sustancias_controladas.pdf1
  9. Poisons Standard. legislation.gov.au (n.d.). https://www.legislation.gov.au/F2025L00049/asmade/2025-01-28/text/original/epub/OEBPS/document_1/document_1.html1
  10. Suchtgiftverordnung. ris.bka.gv.at (n.d.). https://ris.bka.gv.at/NormDokument.wxe?Abfrage=Bundesnormen&Anlage=5&Artikel=&FassungVom=2026-02-07&Gesetzesnummer=10011053&Paragraf=&Uebergangsrecht=1

Further Reading

  1. 5-HT2 receptor binding affinities (Leysen et al. 2004)
  2. ChemSpider: 2C-T-2 Chemical Structure
  3. EMCDDA Risk Assessment: 2C-T-2
  4. Leysen et al. 2004 - 5-HT2 Receptor Binding Affinities
  5. Reddit: field report – first-hand 20 mg oral experience

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Lyrea avatar
    Step 2 · First-pass review

    A first pass manual review and edit of article prose and copy has been performed by subject-matter expert Lyrea. This does not guarantee factual accuracy. An additional human review for each of this article's citations is yet to be performed.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes8 human edits · latest

Times are UTCNewest first

31 July 2026

  1. Lyrea · Updated the article

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the 2C-T-2 article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.